MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services, Forms & Formularies
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Ask Better Questions for Safer Prescription Use

Jul 16, 2026 | MedBen Access, Mobile app, Online Services, Pharmacies, Prescription drugs, Prescription Portal

Nearly one-third of middle-aged Americans struggle with common health tasks, including remembering doctor instructions and properly following medication directions, according to new research. Simple details — when to take a medication, whether to take it with...

Drug Spending Growth Calls for Broader Pharmacy Strategies

Jul 3, 2026 | Acquisition Cost Index (ACI), Benefits preservation, Biosimilar, Client Report, Drug costs, Formularies, MedBen Rx, Rx Costs, Rx Spending, Transparency

U.S. pharmaceutical expenditures rose 12.7% in 2025 to $915.2 billion, according to a recent analysis in the American Journal of Health-System Pharmacy. Utilization drove most of the growth, led by high-cost therapies such as tirzepatide, semaglutide, and apixaban....

Traditional PBMs vs. MedBen Rx: A Side-by-Side Comparison

Jun 22, 2026 | Acquisition Cost Index (ACI), MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, Spread Pricing

MedBen Rx is the fastest growing division of MedBen — and for good reason. Here’s how we stack up against traditional PBMs: CORE STRENGTHS OF MEDBEN RX OVER TRADITIONAL MODELS True Transparency & Pass-Through Traditional PBMs frequently use “spread...

Managing Specialty Drug Spend through Benefit Preservation

May 26, 2026 | Benefits preservation, Drug costs, MedBen Rx, Rx Costs, Specialty Drugs

A recent Pharmaceutical Strategies Group analysis shows managing specialty drug costs is now the top priority for employer health plans —surpassing total cost of care. MedBen Rx’s Benefit Preservation Program addresses this by reducing specialty drug spend by an...

Biosimilars Show Strong Savings, but Broader Adoption Still Lags

May 4, 2026 | Biosimilar, Cost Savings, MedBen Rx, Rx Costs, Rx Spending, Savings

Specialty drugs account for more than half of total drug spend and are often the largest cost driver for employer pharmacy plans. A recent BenefitPRO article points to biosimilars as a practical solution — and for MedBen Rx clients, the...
« Older Entries

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Chronic conditions
  • Claims
  • Client Report
  • Clinical guidance
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Health and Human Services
  • Health systems
  • Heart medications
  • High-value formulary
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Lifestyle
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx News
  • MedBen University
  • Medicaid
  • Medicare
  • Mental health
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Obesity
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Patient assistance program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2026 MedBen Rx. All rights reserved.